Fig. 2From: Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresisLeft panel shows colonoscopy with erythema and inflammation of duodenum. Right panel show a complete resolution of GVHD, 4 weeks after RuxolitinibBack to article page